PSTV logo

Plus Therapeutics (PSTV) Selling, General & Administrative Expenses

Annual SGA

$8.54 M
-$1.69 M-16.55%

December 1, 2023

Summary

Performance

1-Year Change

-16.55%

3-Year Change

+33.37%

5-Year Change

+37.32%

15-Year Change

-23.63%

PSTV SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

18.72%
PSTV annual SGA is higher than 18.72% of companies in Healthcare sector

High & Low

All-time High

$28.29 M
PSTV annual SGA is currently -69.80% below its historical high of $28.29 million

3-Year Low

$6.85 M
PSTV annual SGA is currently +24.68% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
PSTV previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
PSTV next annual earnings announcement has not yet been scheduled

OtherPSTVexpensesmetrics:

Annual Total Expenses

$13.32 M
PSTV annual total expenses is $13.32 million

Annual Operating Expenses

$13.32 M
PSTV annual total operating expenses is $13.32 million

Annual Cost Of Goods Sold

-
PSTV annual cost of goods sold value is unknown

Annual Interest Expense

$395.00 K
PSTV annual interest expense is $395.00 thousand

Quarterly SGA

$2.40 M
+$194.00 K+8.81%

September 1, 2024

Summary

Performance

3-Month Change

+8.81%

1-Year Change

+8.31%

3-Year Change

+11.96%

5-Year Change

+11.96%

PSTV Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

21.01%
PSTV quarterly SGA is higher than 21.01% of companies in Healthcare sector

High & Low

All-time High

$7.86 M
PSTV quarterly SGA is currently -69.52% below its historical high of $7.86 million

3-Year Low

$1.92 M
PSTV quarterly SGA is currently +24.58% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
PSTV previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
PSTV next earnings announcement has not yet been scheduled

OtherPSTVexpensesmetrics:

Quarterly Total Expenses

$3.80 M
PSTV quarterly total expenses is $3.80 million

Quarterly Operating Expenses

$3.80 M
PSTV quarterly total operating expenses is $3.80 million

Quarterly Cost Of Goods Sold

-
PSTV quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$61.00 K
PSTV quarterly interest expense is $61.00 thousand

TTM SGA

-$1.94 B
-$12.88 M-0.67%

September 1, 2024

Summary

Performance

3-Month Change

-22174.18%

1-Year Change

-22897.71%

3-Year Change

-25493.1%

5-Year Change

-25493.1%

PSTV TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

24.69%
PSTV TTM SGA is higher than 24.69% of companies in Healthcare sector

High & Low

All-time High

-$21.45 M

3-Year Low

-$1.94 B
PSTV TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
PSTV previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
PSTV next earnings announcement has not yet been scheduled

OtherPSTVexpensesmetrics:

Annual Total Expenses

$13.32 M
PSTV annual total expenses is $13.32 million

Annual Operating Expenses

$13.32 M
PSTV annual total operating expenses is $13.32 million

TTM Cost Of Goods Sold

-
PSTV TTM cost of goods sold value is unknown

TTM Interest Expense

$3.73 M
PSTV TTM interest expense is $3.73 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$8.54 M
PSTV annual SGA is $8.54 million

Annual Operating Expenses

$13.32 M
PSTV annual total operating expenses is $13.32 million

Annual Cost Of Goods Sold

-
PSTV annual cost of goods sold value is unknown

PSTV Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-16.6%+8.3%-10000.0%
3 y3 years+33.4%+12.0%-10000.0%
5 y5 years+37.3%+12.0%-10000.0%

PSTV Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-16.6%+24.7%-33.1%+24.6%-9.9%at low
5 y5-year-16.6%+61.5%-33.1%+126.1%-14.4%at low
alltimeall time-69.8%+960.0%-69.5%+146.6%-8947.6%at low

Plus Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$2.40 M(+8.8%)
$9.19 M(+4.5%)
Jun 2024
-
$2.20 M(-0.5%)
$8.79 M(+3.3%)
Mar 2024
-
$2.21 M(-6.9%)
$8.51 M(-0.4%)
Dec 2023
$8.54 M(-16.5%)
$2.38 M(+19.0%)
$8.54 M(-12.4%)
Sep 2023
-
$2.00 M(+3.8%)
$9.75 M(-2.2%)
Jun 2023
-
$1.92 M(-14.3%)
$9.98 M(-3.5%)
Mar 2023
-
$2.25 M(-37.4%)
$10.34 M(+1.0%)
Dec 2022
$10.24 M(+49.4%)
$3.58 M(+61.3%)
$10.24 M(+17.7%)
Sep 2022
-
$2.22 M(-2.9%)
$8.69 M(+2.7%)
Jun 2022
-
$2.29 M(+6.9%)
$8.46 M(+10.7%)
Mar 2022
-
$2.14 M(+4.8%)
$7.64 M(+11.5%)
Dec 2021
$6.85 M(+7.0%)
$2.04 M(+2.6%)
$6.85 M(-3.6%)
Sep 2021
-
$1.99 M(+35.5%)
$7.11 M(+15.0%)
Jun 2021
-
$1.47 M(+8.7%)
$6.18 M(+0.7%)
Mar 2021
-
$1.35 M(-41.2%)
$6.14 M(-4.2%)
Dec 2020
$6.41 M(+21.1%)
$2.30 M(+116.9%)
$6.41 M(+10.8%)
Sep 2020
-
$1.06 M(-25.8%)
$5.78 M(-1.9%)
Jun 2020
-
$1.43 M(-11.7%)
$5.89 M(+8.4%)
Mar 2020
-
$1.62 M(-3.2%)
$5.43 M(+2.7%)
Dec 2019
$5.29 M(-15.0%)
$1.67 M(+42.9%)
$5.29 M(+14.9%)
Sep 2019
-
$1.17 M(+20.4%)
$4.61 M(-5.8%)
Jun 2019
-
$972.00 K(-34.2%)
$4.89 M(-17.3%)
Mar 2019
-
$1.48 M(+49.6%)
$5.91 M(-19.6%)
Dec 2018
$6.22 M(-44.4%)
$987.00 K(-32.2%)
$7.36 M(-13.5%)
Sep 2018
-
$1.46 M(-27.0%)
$8.50 M(-12.1%)
Jun 2018
-
$1.99 M(-31.8%)
$9.67 M(-12.5%)
Mar 2018
-
$2.92 M(+37.1%)
$11.06 M(-1.1%)
Dec 2017
$11.19 M(-8.1%)
$2.13 M(-18.8%)
$11.19 M(-5.7%)
Sep 2017
-
$2.63 M(-22.4%)
$11.86 M(-1.7%)
Jun 2017
-
$3.38 M(+11.0%)
$12.07 M(+1.4%)
Mar 2017
-
$3.05 M(+8.5%)
$11.90 M(-2.3%)
Dec 2016
$12.17 M(-2.0%)
$2.81 M(-0.7%)
$12.18 M(+0.9%)
Sep 2016
-
$2.83 M(-12.1%)
$12.07 M(-0.9%)
Jun 2016
-
$3.22 M(-3.1%)
$12.18 M(-1.9%)
Mar 2016
-
$3.32 M(+22.7%)
$12.41 M(-0.1%)
Dec 2015
$12.43 M(-44.4%)
$2.71 M(-7.8%)
$12.43 M(-8.8%)
Sep 2015
-
$2.94 M(-14.8%)
$13.63 M(-16.6%)
Jun 2015
-
$3.45 M(+3.3%)
$16.34 M(-15.9%)
Mar 2015
-
$3.34 M(-14.5%)
$19.43 M(-13.1%)
Dec 2014
$22.36 M(-10.8%)
$3.91 M(-30.9%)
$22.36 M(-10.0%)
Sep 2014
-
$5.65 M(-13.6%)
$24.83 M(-1.8%)
Jun 2014
-
$6.54 M(+4.3%)
$25.30 M(+0.3%)
Mar 2014
-
$6.27 M(-1.7%)
$25.22 M(+0.7%)
Dec 2013
$25.06 M(-0.4%)
$6.38 M(+4.3%)
$25.06 M(+0.5%)
Sep 2013
-
$6.12 M(-5.2%)
$24.94 M(-0.4%)
Jun 2013
-
$6.46 M(+5.8%)
$25.05 M(+0.3%)
Mar 2013
-
$6.10 M(-2.6%)
$24.96 M(-0.8%)
Dec 2012
$25.16 M
$6.26 M(+0.6%)
$25.16 M(-0.9%)
DateAnnualQuarterlyTTM
Sep 2012
-
$6.23 M(-2.2%)
$25.39 M(-3.5%)
Jun 2012
-
$6.37 M(+1.1%)
$26.32 M(-5.4%)
Mar 2012
-
$6.30 M(-3.0%)
$27.82 M(-1.7%)
Dec 2011
$28.29 M(+19.8%)
$6.50 M(-9.2%)
$28.29 M(-1.5%)
Sep 2011
-
$7.16 M(-9.0%)
$28.71 M(+4.2%)
Jun 2011
-
$7.86 M(+16.1%)
$27.55 M(+9.5%)
Mar 2011
-
$6.77 M(-2.2%)
$25.16 M(+6.6%)
Dec 2010
$23.61 M(+38.9%)
$6.92 M(+15.5%)
$23.61 M(+7.2%)
Sep 2010
-
$5.99 M(+9.4%)
$22.03 M(+9.4%)
Jun 2010
-
$5.48 M(+5.0%)
$20.14 M(+9.2%)
Mar 2010
-
$5.22 M(-2.3%)
$18.43 M(+8.5%)
Dec 2009
$17.00 M(+4.1%)
$5.34 M(+30.2%)
$17.00 M(+11.6%)
Sep 2009
-
$4.10 M(+8.8%)
$15.23 M(-1.9%)
Jun 2009
-
$3.77 M(-0.2%)
$15.53 M(-3.2%)
Mar 2009
-
$3.78 M(+5.7%)
$16.04 M(-1.8%)
Dec 2008
$16.33 M(-3.1%)
$3.58 M(-18.8%)
$16.33 M(-10.1%)
Sep 2008
-
$4.41 M(+3.0%)
$18.16 M(+3.5%)
Jun 2008
-
$4.28 M(+5.2%)
$17.54 M(+1.9%)
Mar 2008
-
$4.07 M(-24.7%)
$17.21 M(+2.1%)
Dec 2007
$16.86 M(+15.4%)
$5.40 M(+42.5%)
$16.86 M(+16.5%)
Sep 2007
-
$3.79 M(-4.1%)
$14.47 M(-0.0%)
Jun 2007
-
$3.95 M(+6.5%)
$14.47 M(-0.9%)
Mar 2007
-
$3.71 M(+23.2%)
$14.60 M(-0.0%)
Dec 2006
$14.60 M(+24.2%)
$3.01 M(-20.5%)
$14.60 M(-6.6%)
Sep 2006
-
$3.79 M(-7.1%)
$15.63 M(+5.9%)
Jun 2006
-
$4.08 M(+9.8%)
$14.76 M(+12.0%)
Mar 2006
-
$3.72 M(-7.9%)
$13.17 M(+10.6%)
Dec 2005
$11.76 M(+31.1%)
$4.04 M(+38.3%)
$11.91 M(+13.8%)
Sep 2005
-
$2.92 M(+16.9%)
$10.47 M(+10.1%)
Jun 2005
-
$2.50 M(+1.7%)
$9.51 M(+2.9%)
Mar 2005
-
$2.46 M(-5.3%)
$9.24 M(+3.0%)
Dec 2004
$8.96 M(-0.4%)
$2.60 M(+32.7%)
$8.96 M(+4.4%)
Sep 2004
-
$1.96 M(-12.2%)
$8.59 M(-5.8%)
Jun 2004
-
$2.23 M(+2.1%)
$9.11 M(+3.1%)
Mar 2004
-
$2.18 M(-1.6%)
$8.84 M(-1.8%)
Dec 2003
$9.00 M(+13.3%)
$2.22 M(-10.6%)
$9.00 M(-0.8%)
Sep 2003
-
$2.48 M(+26.9%)
$9.07 M(+5.8%)
Jun 2003
-
$1.96 M(-16.6%)
$8.57 M(+0.9%)
Mar 2003
-
$2.34 M(+2.2%)
$8.50 M(+38.1%)
Dec 2002
$7.94 M(-1.6%)
$2.29 M(+15.7%)
$6.16 M(+14.4%)
Sep 2002
-
$1.98 M(+5.3%)
$5.38 M(-5.1%)
Jun 2002
-
$1.88 M(+23.9%)
$5.67 M(-7.6%)
Dec 2001
$8.07 M(+55.7%)
$1.52 M(-33.1%)
$6.13 M(+32.9%)
Sep 2001
-
$2.27 M(-3.2%)
$4.61 M(+96.8%)
Jun 2001
-
$2.34 M
$2.34 M
Dec 2000
$5.18 M(+41.3%)
-
-
Dec 1999
$3.67 M(+355.2%)
-
-
Dec 1998
$806.00 K
-
-

FAQ

  • What is Plus Therapeutics annual SGA?
  • What is the all time high annual SGA for Plus Therapeutics?
  • What is Plus Therapeutics annual SGA year-on-year change?
  • What is Plus Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Plus Therapeutics?
  • What is Plus Therapeutics quarterly SGA year-on-year change?
  • What is Plus Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Plus Therapeutics?
  • What is Plus Therapeutics TTM SGA year-on-year change?

What is Plus Therapeutics annual SGA?

The current annual SGA of PSTV is $8.54 M

What is the all time high annual SGA for Plus Therapeutics?

Plus Therapeutics all-time high annual SGA is $28.29 M

What is Plus Therapeutics annual SGA year-on-year change?

Over the past year, PSTV annual SGA has changed by -$1.69 M (-16.55%)

What is Plus Therapeutics quarterly SGA?

The current quarterly SGA of PSTV is $2.40 M

What is the all time high quarterly SGA for Plus Therapeutics?

Plus Therapeutics all-time high quarterly SGA is $7.86 M

What is Plus Therapeutics quarterly SGA year-on-year change?

Over the past year, PSTV quarterly SGA has changed by +$184.00 K (+8.31%)

What is Plus Therapeutics TTM SGA?

The current TTM SGA of PSTV is -$1.94 B

What is the all time high TTM SGA for Plus Therapeutics?

Plus Therapeutics all-time high TTM SGA is -$21.45 M

What is Plus Therapeutics TTM SGA year-on-year change?

Over the past year, PSTV TTM SGA has changed by -$1.95 B (-22897.71%)